Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study. - Celsa C; Pressiani T; Nishida N; Chamseddine SM; Arvind A; Li M; Fortuny M; Khaled NB; Iavarone M; Toyoda H; Rapposelli IG; Casadei-Gardini A; et al. (JHEP reports : innovation in hepatology, 2025)